Nothing Special   »   [go: up one dir, main page]

Chang et al., 2018 - Google Patents

The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders

Chang et al., 2018

View HTML
Document ID
5954750288901089268
Author
Chang H
Hoshina N
Zhang C
Ma Y
Cao H
Wang Y
Wu D
Bergen S
Landén M
Hultman C
Preisig M
Kutalik Z
Castelao E
Grigoroiu-Serbanescu M
Forstner A
Strohmaier J
Hecker J
Schulze T
Müller-Myhsok B
Reif A
Mitchell P
Martin N
Schofield P
Cichon S
Nöthen M
Walter H
Erk S
Heinz A
Amin N
Van Duijn C
Meyer-Lindenberg A
Tost H
Xiao X
Yamamoto T
Rietschel M
Li M
Publication year
Publication venue
Molecular psychiatry

External Links

Snippet

Major mood disorders, which primarily include bipolar disorder and major depressive disorder, are the leading cause of disability worldwide and pose a major challenge in identifying robust risk genes. Here, we present data from independent large-scale clinical …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/24—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for machine learning, data mining or biostatistics, e.g. pattern finding, knowledge discovery, rule extraction, correlation, clustering or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Similar Documents

Publication Publication Date Title
Chang et al. The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders
Girgenti et al. Transcriptomic organization of the human brain in post-traumatic stress disorder
International Multiple Sclerosis Genetics Consortium http://orcid. org/0000-0003-2616-7274 Harroud Adil 1 78 78 Stridh Pernilla 2 McCauley Jacob L. 3 4 Saarela Janna 5 6 van den Bosch Aletta MR 7 Engelenburg Hendrik J. 7 Beecham Ashley H. 3 Alfredsson Lars 2 Alikhani Katayoun 8 Amezcua Lilyana 9 Andlauer Till FM 10 Ban Maria 11 Barcellos Lisa F. 12 Barizzone Nadia 13 Berge Tone 14 15 Berthele Achim 10 Bittner Stefan 16 Bos Steffan D. 17 18 Briggs Farren BS 19 Caillier Stacy J. 1 Calabresi Peter A. 20 Caputo Domenico 21 Carmona-Burgos David X. 22 Cavalla Paola 23 Celius Elisabeth G. 17 18 Cerono Gabriel 1 Chinea Angel R. 22 24 Chitnis Tanuja 25 26 Clarelli Ferdinando 27 Comabella Manuel 28 Comi Giancarlo 29 30 Cotsapas Chris 31 32 Cree Bruce CA 1 D’Alfonso Sandra 13 Dardiotis Efthimios 33 De Jager Philip L. 34 Delgado Silvia R. 35 Dubois Bénédicte 36 37 Engel Sinah 16 Esposito Federica 38 Fabis-Pedrini Marzena J. 39 40 Filippi Massimo 30 41 Fitzgerald Kathryn C. 20 Gasperi Christiane 10 Gomez Lissette 3 Gomez Refujia 1 Hadjigeorgiou Georgios 42 Hamann Jörg 7 43 Held Friederike 10 Henry Roland G. 1 Hillert Jan 2 Huang Jesse 2 Huitinga Inge 7 44 Islam Talat 45 Isobe Noriko 46 Jagodic Maja 2 Kermode Allan G. 40 47 Khalil Michael 48 Kilpatrick Trevor J. 49 50 51 Konidari Ioanna 3 Kreft Karim L. 52 Lechner-Scott Jeannette 53 54 Leone Maurizio 55 Luessi Felix 16 Malhotra Sunny 28 Manouchehrinia Ali 2 Manrique Clara P. 3 Martinelli-Boneschi Filippo 56 57 Martinez Andrea C. 9 Martinez-Maldonado Viviana 22 Mascia Elisabetta 27 Metz Luanne M. 8 Midaglia Luciana 28 Montalban Xavier 28 Oksenberg Jorge R. 1 Olsson Tomas 2 Oturai Annette 58 Pääkkönen Kimmo 6 Parnell Grant P. 59 60 Patsopoulos Nikolaos A. 61 62 63 Pericak-Vance Margaret A. 3 4 Piehl Fredrik 2 Rubio Justin P. 50 51 Santaniello Adam 1 Santoro Silvia 27 Schaefer Catherine 64 Sellebjerg Finn 58 65 Shams Hengameh 1 Shchetynsky Klementy 2 66 Silva Claudia 8 Siokas Vasileios 33 Søndergaard Helle B. 58 Sorosina Melissa 27 Taylor Bruce 67 Vandebergh Marijne 37 Vasileiou Elena S. 20 Vecchio Domizia 68 Voortman Margarete M. 48 Weiner Howard L. 25 26 Wever Dennis 7 Yong V. Wee 8 Hafler David A. 61 69 Stewart Graeme J. 70 71 Compston Alastair 11 Zipp Frauke 16 Harbo Hanne F. 17 18 Hemmer Bernhard 10 72 Goris An 37 Smolders Joost 7 73 Hauser Stephen L. 1 Kockum Ingrid 2 http://orcid. org/0000-0001-7685-0974 Sawcer Stephen J. sjs1016@ cam. ac. uk 11 dx http://orcid. org/0000-0003-0067-194X Baranzini Sergio E. sergio. baranzini@ ucsf. edu 1 dy et al. Locus for severity implicates CNS resilience in progression of multiple sclerosis
Gazzellone et al. Uncovering obsessive-compulsive disorder risk genes in a pediatric cohort by high-resolution analysis of copy number variation
Cattaneo et al. FoxO1, A2M, and TGF-β1: three novel genes predicting depression in gene X environment interactions are identified using cross-species and cross-tissues transcriptomic and miRNomic analyses
Toulopoulou et al. Polygenic risk score increases schizophrenia liability through cognition-relevant pathways
Starnawska et al. Epigenome-wide association study of depression symptomatology in elderly monozygotic twins
Levinson et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications
Frey et al. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force
Zhou et al. Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals
Zeidán-Chuliá et al. Altered expression of Alzheimer’s disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapy
Fitzgerald et al. Early complement genes are associated with visual system degeneration in multiple sclerosis
Jalbrzikowski et al. Transcriptome profiling of peripheral blood in 22q11. 2 deletion syndrome reveals functional pathways related to psychosis and autism spectrum disorder
Lu et al. A comprehensive gene-centric pleiotropic association analysis for 14 psychiatric disorders with GWAS summary statistics
Freytag et al. A peripheral epigenetic signature of immune system genes is linked to neocortical thickness and memory
Viswanath et al. Discovery biology of neuropsychiatric syndromes (DBNS): a center for integrating clinical medicine and basic science
Hüls et al. Association between DNA methylation levels in brain tissue and late-life depression in community-based participants
Giacalone et al. Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis
Kashimada et al. Genetic analysis of undiagnosed ataxia-telangiectasia-like disorders
Kular et al. DNA methylation changes in glial cells of the normal-appearing white matter in Multiple Sclerosis patients
Kos et al. Exome sequences of multiplex, multigenerational families reveal schizophrenia risk loci with potential implications for neurocognitive performance
Baranzini et al. Genetic analysis of multiple sclerosis severity identifies a novel locus and implicates CNS resilience as a major determinant of outcome
Hope et al. Bidirectional genetic overlap between autism spectrum disorder and cognitive traits
Ruggeri et al. Methylation of OPRL 1 mediates the effect of psychosocial stress on binge drinking in adolescents
Corvin et al. The cognitive genetics of neuropsychiatric disorders